Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.53 |
| ▸ | GHSR | Q92847 | 6/20 | 0.43 |
| ▸ | HPGDS | O60760 | 1/20 | 0.38 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.37 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.37 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.37 |
| ▸ | ROCK2 | O75116 | 3/20 | 0.37 |
| ▸ | PRKACA | P17612 | 1/20 | 0.37 |
| ▸ | AKT3 | Q9Y243 | 1/20 | 0.37 |
| ▸ | TLR2 | O60603 | 1/20 | 0.36 |
| ▸ | QRFPR | Q96P65 | 1/20 | 0.35 |
| ▸ | CTSL | P07711 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10595108 | 0.91 | SLC15A2 (0.64) | SLC15A2GHSRERAP2LNPEP | |
| SCHEMBL8832939 | 0.91 | SLC15A2 (0.64) | SLC15A2GHSRERAP2LNPEP | |
| SCHEMBL5598418 | 0.91 | SLC15A2 (0.64) | SLC15A2GHSRERAP2LNPEP | |
| SCHEMBL259085 | 0.91 | SLC15A2 (0.64) | SLC15A2GHSRERAP2LNPEP | |
| SCHEMBL259084 | 0.91 | SLC15A2 (0.64) | SLC15A2GHSRERAP2LNPEP | |
| SCHEMBL31467761 | 0.91 | SLC15A2 (0.46) | SLC15A2ROCK2 | |
| SCHEMBL4589314 | 0.90 | SLC15A2 (0.63) | SLC15A2GHSRERAP2LNPEP | |
| SCHEMBL4589903 | 0.90 | SLC15A2 (0.63) | SLC15A2GHSRERAP2LNPEP | |
| SCHEMBL2817828 | 0.90 | SLC15A2 (0.63) | SLC15A2GHSRERAP2LNPEP | |
| SCHEMBL2815080 | 0.90 | SLC15A2 (0.63) | SLC15A2GHSRERAP2LNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0288278-B1 | Chemical derivatives of GHL-CU | PROCYTE CORP (US) | 1994-03-30 | — | — | EP | disclosed |
| EP-0190736-B1 | Chemical derivatives of GHL-Cu | PROCYTE CORP (US) | 1993-12-15 | — | — | EP | disclosed |
| EP-0190048-B1 | BURSOPOIETIN | ORTHO PHARMACEUTICAL CORPORATION (US) | 1992-01-22 | — | — | EP | disclosed |
| US-4877770-A | GLYCYL-HISTIDYL-LYSINE: COPPER WOUND HEALING AGENTS | PROCYTE CORPORATION (US) | 1989-10-31 | — | — | US | disclosed |
| US-4866121-A | B cell differentiating peptides and conjugates thereof | ORTHO PHARMACEUTICAL CORPORATION (US) | 1989-09-12 | — | — | US | disclosed |
| US-4783442-A | B-cell differentiating peptides | ORTHO PHARMACEUTICAL CORPORATION (US) | 1988-11-08 | — | — | US | disclosed |
| EP-0288278-A2 | Chemical derivatives of GHL-CU | PROCYTE CORPORATION (US) | 1988-10-26 | — | — | EP | disclosed |
| US-4665054-A | GLYCYL-HISTIDYL-LYSINE COPPER CHELATE | BIOHEAL, INC. (US) | 1987-05-12 | — | — | US | disclosed |
| EP-0190736-A2 | Chemical derivatives of GHL-Cu | PROCYTE CORPORATION (US) | 1986-08-13 | — | — | EP | disclosed |
| EP-0190048-A2 | Bursopoietin | ORTHO PHARMACEUTICAL CORPORATION (US) | 1986-08-06 | — | — | EP | disclosed |
| US-4584284-A | OLIGOPEPTIDE OF LYSINE, HISTIDINE AND GLYCINE-PRODUCING ANTIBODIES | ORTHO PHARMACEUTICAL CORPORATION (US) | 1986-04-22 | — | — | US | disclosed |